CARNITINE DERIVATIVE-CONTAINING MEDICAMENT FOR TREATING CHRONIC ARTERIOSCLEROSIS OBLITERANS

摘要

The use of propionyl L-carnitine and pharmacologically acceptablesalts thereof is disclosed for producing a medicament for treating chronicarteriosclerosis obliterans which is selectively suited for the treatment ofpatients with severely disabling intermittent claudication.